Literature DB >> 22575053

A facile quantitative assay for viral particle genesis reveals cooperativity in virion assembly and saturation of an antiviral protein.

Shalini S Yadav1, Sam J Wilson, Paul D Bieniasz.   

Abstract

Conventional assays of viral particle assembly and release are time consuming and laborious. We have developed an enzymatic virus-like particle (VLP) genesis assay that rapid and quantitative and is also versatile and applicable to diverse viruses including HIV-1 and Ebola virus. Using this assay, which has a dynamic range of several orders of magnitude, we show that the efficiency of VLP assembly and release, i.e., the fraction of the expressed protein that is assembled into extracellular particles, is dependent on the absolute level of expression of either HIV-1 Gag or Ebola virus VP40. We also demonstrate that the activity of the antiviral factor tetherin is dependent on the level of HIV-1 Gag expression and the numbers of VLPs generated, and appears to become saturated as these parameters are increased.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22575053      PMCID: PMC3419437          DOI: 10.1016/j.virol.2012.04.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells.

Authors:  Theodora Hatziioannou; Juan Martin-Serrano; Trinity Zang; Paul D Bieniasz
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.

Authors:  W Zhou; M D Resh
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  Development of a rapid and convenient method for the quantification of HIV-1 budding.

Authors:  Sayuri Sakuragi; Jun-ichi Sakuragi; Yuko Morikawa; Tatsuo Shioda
Journal:  Microbes Infect       Date:  2006-05-19       Impact factor: 2.700

4.  Vesicular release of ebola virus matrix protein VP40.

Authors:  J Timmins; S Scianimanico; G Schoehn; W Weissenhorn
Journal:  Virology       Date:  2001-04-25       Impact factor: 3.616

5.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

6.  Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.

Authors:  Kathleen Fitzpatrick; Mark Skasko; Thomas J Deerinck; John Crum; Mark H Ellisman; John Guatelli
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

7.  Context-dependent effects of L domains and ubiquitination on viral budding.

Authors:  Juan Martin-Serrano; David Perez-Caballero; Paul D Bieniasz
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.

Authors:  Althea A Capul; Juan Carlos de la Torre
Journal:  Virology       Date:  2008-10-16       Impact factor: 3.616

9.  HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.

Authors:  Stuart J D Neil; Scott W Eastman; Nolwenn Jouvenet; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2006-05-12       Impact factor: 6.823

10.  The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties.

Authors:  F Xavier Gomis-Rüth; Andréa Dessen; Joanna Timmins; Andreas Bracher; Larissa Kolesnikowa; Stephan Becker; Hans Dieter Klenk; Winfried Weissenhorn
Journal:  Structure       Date:  2003-04       Impact factor: 5.006

View more
  7 in total

1.  Interactions between HIV-1 Gag and Viral RNA Genome Enhance Virion Assembly.

Authors:  Kari A Dilley; Olga A Nikolaitchik; Andrea Galli; Ryan C Burdick; Louis Levine; Kelvin Li; Alan Rein; Vinay K Pathak; Wei-Shau Hu
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Functional redundancy in HIV-1 viral particle assembly.

Authors:  Ina P O'Carroll; Rachael M Crist; Jane Mirro; Demetria Harvin; Ferri Soheilian; Anne Kamata; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

3.  Subcellular Localization of HIV-1 gag-pol mRNAs Regulates Sites of Virion Assembly.

Authors:  Jordan T Becker; Nathan M Sherer
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

4.  Could the Ebola virus matrix protein VP40 be a drug target?

Authors:  Robert V Stahelin
Journal:  Expert Opin Ther Targets       Date:  2013-11-28       Impact factor: 6.902

5.  A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Weiming Wang; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

Review 6.  Counteraction of the multifunctional restriction factor tetherin.

Authors:  Daniel Sauter
Journal:  Front Microbiol       Date:  2014-04-10       Impact factor: 5.640

7.  Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins.

Authors:  Florian Wrensch; Markus Hoffmann; Sabine Gärtner; Inga Nehlmeier; Michael Winkler; Stefan Pöhlmann
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.